875 CA-4948 alters tumor associated macrophage activity in the tumor microenvironment of murine models of melanoma metastases

875 CA-4948 alters tumor associated macrophage activity in the tumor microenvironment of murine models of melanoma metastases

Bibliographic Details
Main Authors:	Duane A Mitchell, Christina Von Roemeling, Bently Doonan, Rylynn Russell, Amanda Acevedo, Savannah Carpenter, Nicholas Hincapie, Yousif Shakoury
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA
by: C. Von Roemeling, et al.
Published: (2022-06-01)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
by: Dimitri G. Trembath, et al.
Published: (2021-01-01)

772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy
by: Duane A Mitchell, et al.
Published: (2023-11-01)

M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
by: Magdalena Jarosz-Biej, et al.
Published: (2018-01-01)

Tumor microenvironment differences between primary tumor and brain metastases
by: Bernardo Cacho-Díaz, et al.
Published: (2020-01-01)

Melanoma: tumor microenvironment and new treatments
by: Mara Huffenbaecher Giavina-Bianchi, et al.
Published: (2017-03-01)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
by: Vrunda Trivedi, et al.
Published: (2024-01-01)

P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
by: E. Joffe, et al.
Published: (2022-06-01)

Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma
by: Lara Goesmann, et al.
Published: (2023-05-01)

CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma
by: Fatemeh Talebian, et al.
Published: (2021-10-01)

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
by: Daiki Ikarashi, MD, PhD, et al.
Published: (2021-10-01)

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
by: Gino K. In, et al.
Published: (2023-11-01)

Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC
by: Qing LAN, et al.
Published: (2019-08-01)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
by: Wencheng Zhou, et al.
Published: (2022-12-01)

Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
by: Angelica Avagliano, et al.
Published: (2020-05-01)

Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma
by: Alessandro Giammona, et al.
Published: (2024-08-01)

Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
by: Siyu Zhou, et al.
Published: (2023-04-01)

Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases
by: Markus Kleinberger, et al.
Published: (2025-02-01)

Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC
by: Jin-Sheng Liu, et al.
Published: (2024-01-01)

Murine brain tumor microenvironment immunophenotyping using mass cytometry
by: Brandon L. McClellan, et al.
Published: (2022-06-01)

Evolution of tumor microenvironment in colorectal liver metastases under treatment stress
by: Na Huang, et al.
Published: (2022-05-01)

Characterization of the immune microenvironment in brain metastases from different solid tumors
by: Jinling Jiang, et al.
Published: (2020-04-01)

Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases
by: Yiqiao Deng, et al.
Published: (2025-01-01)

Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis
by: Alberto Benito-Martín, et al.
Published: (2023-01-01)

Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis
by: Chuan Zhang, et al.
Published: (2021-07-01)

Detection of viable commensal bacteria in murine melanoma tumors by culturomics
by: Catherine M. Phelps, et al.
Published: (2023-09-01)

S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INHIBITOR EMAVUSERTIB (CA-4948) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN RELAPSED/REFRACTORY AML OR MDS
by: G. Garcia-Manero, et al.
Published: (2022-06-01)

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
by: Christina A. von Roemeling, et al.
Published: (2024-07-01)

Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer
by: Sin Mun Tham, et al.
Published: (2011-01-01)

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases
by: Prakadan, Sanjay M, et al.
Published: (2022)

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases
by: Ryosuke Ogata, et al.
Published: (2022-10-01)

Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
by: Colleen Chute, et al.
Published: (2018-07-01)

Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
by: Claire L. Ihle, et al.
Published: (2019-11-01)

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases
by: Sanjay M. Prakadan, et al.
Published: (2021-10-01)

Comparison of Mir-211 Expression in Murine Melanoma Cell Line and Murine Melanoma Tumor by Real-Time Polymerase Chain Reaction
by: Vahid Bahrambeigi, et al.
Published: (2012-11-01)

Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma
by: L. Parra-Navarro, et al.
Published: (2024-01-01)

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
by: John F Thompson, et al.
Published: (2022-09-01)

Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma
by: Wenqiong Chen, et al.
Published: (2024-01-01)

PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma
by: Xuemei Li, et al.
Published: (2023-11-01)

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment
by: Li Zhang, et al.
Published: (2023-05-01)